Blood Collection Market By Product Type (Needles and Syringes, Blood Collection Tubes, Blood Bags, Lancets, Others), By Method (Manual Blood Collection, Automated Blood Collection), By Application (Diagnostics, Therapeutic), By Material (Plastic, Glass, Stainless Steel, Rubber), By Distribution Channel (Direct Tenders, Retail Pharmacies, Online Sales, Distributors and Wholesalers, Others), and By End-user (Hospitals and Clinics, Diagnostic Laboratories, Blood Banks, Ambulatory Surgical Centers, Home Healthcare Settings, Research & Academic Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape this market in the coming years?

The Blood Collection market accounted for USD 6.2 Billion in 2024 and USD 6.71 Billion in 2025 is expected to reach USD 14.9 Billion by 2035, growing at a CAGR of around 8.3% between 2025 and 2035. The blood collection market can be defined as the business related to gathering, processing, storing, and transporting the blood products and components that have medical applications as well as research. It is also used in crucial scenarios such as diagnostics, surgeries, transfusions, and the treatment of diseases, where hospitals, blood banks, diagnostic labs, and bio firms support it. Such a market consists of various products that include blood collection tubes, needles, syringes, blood bags, and lancets, and the devices used in the market include blood collection monitors and mixers.

In addition, the growing popularity of automated and safety-enhanced technologies for collecting blood contributes to the minimization of the risk of contamination and enhancing efficiency. Policies to regulate standards of healthy and fair measurement of practices within different health environments also enhance the growth of the market. Patients and healthcare workers are increasingly being made safe by the use of more and more technological innovations like vacuum-based systems or closed-loop collection devices that ensure accurate sampling, and there is less wastage of blood. 

What do industry experts say about the market trends?

“Our self-collection kit enables nearly pain-free blood sampling with a 99.9% processing success rate in clinical testing.”

• Jerome Scelza, Co-CEO, Drawbridge Health

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the market?

Increasing demand for early disease detection and regular health screenings.

The growing demand for early disease detection, as well as frequent health screens, accounts for one of the major engines of the blood collection market. The growing interest in determining the health status through regular testing of blood samples has led to an increase in people who are submitting health-related parameters and requiring subsequent testing of the levels of cholesterol and glucose in the body, as well as specific indicators of chronic or infectious diseases. Blood samples are needed to identify conditions at their onset so that they can be intervened in and improved treatment outcomes produced. The growing level of diagnostic procedures in turn is a direct stimulant of safe and convenient blood collecting systems, that is, tubes, syringes, and sophisticated safety equipment.

Adding credence to the trend, the Centers for Disease Control and Prevention (CDC) observes that routine blood tests are crucial in handling the 6 out of 10 adults in the U.S. who are living with at least one chronic disease. Such figures make the frequency of health screening particularly important and, consequently, the infrastructure that the collection and handling of blood should be both safe and efficient. Due to this, quality blood collection products are being invested in by the healthcare systems to support the increase in the need for diagnostic procedures.

Rising prevalence of chronic conditions such as cancer, anemia, and kidney disease..

The increased incidence of chronic diseases like cancer, anemia, and kidney disease is a major driving factor of the blood collection market. Non-communicable diseases are on the rise in the world, and this means that the need for regular blood tests to diagnose, monitor, and treat the conditions has increased vastly. They include a significant percentage of the morbidity and mortality associated with chronic diseases such as cardiovascular disease, cancers, diabetes, and chronic respiratory diseases, which are among others. Cell separation is also equally important, as a robust blood collection system is necessary to check the anemia, the efficiency of the kidneys, to check the biomarkers in case of cancer, or to monitor the progression of the treatment.

Specifically, the increasingly prevalent occurrence of anemia and chronic kidney illness among aging groups has aggravated the necessity of frequent blood tests. As an example, a significant number of adults have chronic kidney disease, which makes the amount of testing important. With the health systems seeking earlier identification and improved disease management processes, the usage of high-quality blood collection products, including such types as tubes, syringes, and modern safety devices, demonstrates an ongoing increase. Such a trend leads to long-term opportunities for manufacturers and suppliers to come up with innovations and generate the rising market demand.

Risk of needle-stick injuries and cross-contamination during manual blood collection.

The concern with needle sticks and contamination by cross-contamination during manual blood collection acts as a major restraining factor on the blood collection market. Accidental needle sticks present a serious safety concern to healthcare workers since such accidents expose them to many infectious agents, such as HIV and hepatitis. Improper handling and disposal are more likely to occur when the procedure requires manual access to high-volume environments or resource-limited cultures.

This also puts not only the medical staff in danger but also endangers the safety of the patients due to potential cross-contamination. With such risks, regulatory bodies have been putting more eyes on these concerns; hence, compliance is more complex and expensive on the part of the manufacturers. This has made healthcare providers reluctant to use or even to continue using old methods of blood collection without introducing new safety aspects that would improve the situation and thus restrict the growth of the concerned regions in the market.

Growing demand for point-of-care blood collection in home and telehealth settings.

The developing need for point-of-care blood collection within home and telehealth environments becomes a valuable opportunity for the blood collection market. With the increased use of more patient-focused and remote care delivery, there is an increase in the demand for easy-to-use, small-sized blood collection devices. In home-based monitoring, patients with chronic illnesses, the aged, and the rural residents are becoming very fond of it as a way of minimizing the number of times they spend in hospitals.

This phenomenon is increasing the rate of advancement and usage of minimally invasive self-collection kits and mail-in testing services. Blood sample collection is also being incorporated by telehealth providers as part of the diagnostic services in a bid to improve the accuracy of remote care. The switch presents new market categories to the manufacturers and promotes innovation of user-friendly, safe, and compact technologies for blood collection.

Rising investments in healthcare infrastructure across emerging economies.

The blood collection market has a good opportunity with the increase in spending on the healthcare infrastructure of the emerging economies. Countries and other individual investors in regions, such as Asia, Africa, or Latin America, are progressively spending funds to improve hospitals, diagnostic laboratories, and primary care institutions. The increases brought by these advances are usually accompanied by diagnostic abilities and consequently directly raise the demand for blood collection equipment and supplies.

Routine screening and blood sampling-related treatment are increasingly becoming more common, and thus, more people are being subjected to these procedures as access to healthcare increases. Also, there is the enhancement of the local manufacturing and distribution channels so that blood collection products could be more accessible and at affordable prices. It is the kind of growth environment that has stimulated global and regional players to explore new and underserved markets that have high long-term potential.

What are the key market segments in the industry?

Based on the product type, the Blood Collection market has been classified into Needles and Syringes, Blood Collection Tubes, Blood Bags, and Lancets. The most prevailing segment in the blood collection market is the Blood Collection Tubes segment. Such tubes are crucial in storing, transporting, and examining blood specimens in diagnostic centers and hospitals. They are making it robust because of their high diagnostic tests carried out all over the world in the form of routine blood tests, detection of diseases, as well as monitoring of chronic diseases. The increased requirements in pre-analytical quality and safety of the samples also promote their embracement.

The fact that blood collection tubes are designed in a variety of types depending on the test to which they are dedicated helps them be useful in many situations in the medical field. They have also become more efficient and reliable with all the improvements in the materials that tubes are made of, vacuum technology, and labeling characteristics. The mounting concern in automated laboratory systems has further enhanced the requirement for standard, high-quality tubes that match the analyzers. This is because of its critical role in the proper and safe sampling of blood, as across the world, diagnostic awareness and the management of chronic diseases engulf many countries and patients.

Based on the application, the Blood Collection market has been classified into Manual Blood Collection, Automated Blood Collection. The most superior method in the blood collection market is called Manual Blood Collection. The reason why this method is still popular is that it is less expensive, simple, and does not require high-level infrastructure, and therefore can be applied to both developed and pre-developed healthcare environments. It is mainly done with the use of needles, syringes, as well as blood collection tubes, which are easily accessible and known by medical practitioners.

Manual techniques are used in daily diagnostic testing, blood donations, and small-scale clinical environments where automation is not required or is impractical due to costs. Moreover, manual collection is flexible, and so it is easy to operate in different patient conditions and the necessities of samples with less-dragged healthcare workers. Even though automated collection is on its way up, particularly in large hospitals and blood banks, the worldwide availability and the reduced cost of operation of manual systems guarantee that it will remain dominant in both the urban and rural medical settings.

Which regions are leading the market, and why?

North America's blood collection market is among the most developed and technologically superior in the world due to well-established healthcare infrastructure and heavy investments in healthcare. The U.S contributes the highest percentage in the region, which is backed by an increased number of surgical operations, increased need for blood donation, as well as dominance of major market players including Becton, Dickinson and Company and Haemonetics Corporation. The region is also enjoying high diagnostic facilities, wide information campaigns, and high regulations, which enhance proper and effective blood collection practices.

Market growth is also enhanced by government activities of agencies such as the American Red Cross and Health Canada, which promote voluntary blood donations. Also, the growing number of chronicle illnesses, cancer, and trauma patients in the area is constantly increasing the demand for blood transfusions and diagnosis. Adoption of automated and closed-loop blood collection technologies that increase safety and minimize the possibility of contamination is also advanced in North America. The fact that the region is continuing its investments in R&D and digitization of the healthcare system also benefits the regional leadership in this market.

The Asia Pacific blood collection market is also growing at a very high rate because of rising healthcare infrastructure, awareness level on blood donation, and the rising level of patients. Other major sources are countries such as China, India, and Japan, which are under the impact of the high burden of the incidence of chronic diseases, the growth of diagnostic services, and the initiative by the governments on blood donation. Due to its large population base and rapidly growing number of hospitals and diagnostic labs, the region is contributing to the demand for superior blood collection products.

Inflow of foreign investments and joint ventures with local players are assisting in transferring new technologies in the region. Also, increasing scare related to transfusion-transmitted infection is encouraging the medical professionals to put stronger safety measures and make use of closed-system blood collection equipment. Nonetheless, differences in access to health services and the regulations availed to others are a challenge among nations. Altogether, the vast region of Asia Pacific has robust growth potential for blood collection corporations on the basis of size, unmet needs, and enhanced healthcare investments.  

What does the competitive landscape of the market look like?

The blood collection market is competitive with both global and regional companies, with the highest level of devices, consumables, and solutions. Large organizations such as Becton, Dickinson and Company, Terumo Corporation, or Fresenius Kabi enjoy many market shares because of having large portfolios of products, global distribution globally and technological innovation in blood collection devices. Such players spend a lot on research and development in terms of increasing safety, precision, and efficiency, especially in regard to vacuum-based systems and automated blood collection devices.

Mergers, acquisitions, and strategic alliances are also on the agenda of the companies that are intent on growing their market share and geographical coverage. The competitive strategy used by the smaller and regional players is the low-cost products on the one hand, and catering to specific niches and local demands on the other hand, especially in developing countries. Furthermore, the increasing trends in safety aspects, including needle-guarded injury and enclosed-system contraptions, are impelling competitors to divvy up their services and products. Of further importance to competitive positioning include regulatory compliance, product approvals, and third-party certification, including the FDA, CE mark, and so on. All in all, innovation, cost competitiveness, regulatory compliance, and worldwide distribution are some of the fundamental factors that determine the dynamics of competition in this market.

Blood Collection Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the industry?

• In April 2024, Streck launched the Protein Plus BCT, a specialized blood collection tube. It helps preserve plasma proteins at room temperature, improving sample stability for research and diagnostics.

Report Coverage:

By Product Type

• Needles and Syringes
• Blood Collection Tubes
• Blood Bags
• Lancets
• Others

By Method

• Manual Blood Collection
• Automated Blood Collection

By Application

•  Diagnostics
• Therapeutic

By Material

• Plastic
• Glass
• Stainless Steel
• Rubber

By Distribution Channel

• Direct Tenders
• Retail Pharmacies
• Online Sales
• Distributors and Wholesalers
• Others

By End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Blood Banks
• Ambulatory Surgical Centers
• Home Healthcare Settings
• Research & Academic Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Becton, Dickinson and Company
• Terumo Corporation
• Fresenius Kabi
• Grifols, S.A.
• Haemonetics Corporation
• Greiner Bio-One International GmbH
• Nipro Corporation
• SARSTEDT AG & Co. KG
• Macopharma
• Quest Diagnostics
• Retractable Technologies, Inc.
• Smiths Medical
• Cardinal Health, Inc.
• Medtronic plc
• Bio-Rad Laboratories, Inc.

Frequently Asked Questions (FAQs)